Call Me Free Offline Send SMS
+918068211495
Home » Products » Hepatitis C Medicine » Ledipasvir + Sofosbuvir Tablet

Ledipasvir + Sofosbuvir Tablet

Ledipasvir + Sofosbuvir Tablet
Ledipasvir + Sofosbuvir Tablet
Send Inquiry
Product Code : 06
Price And Quantity
  • Minimum Order Quantity
  • 100
  • Unit of Measure
  • box
Product Specifications
  • Formulations Form
  • Tablets
  • Gender/Age Group
  • Suitable For All Ages
  • Storage Instructions
  • Store in Cool
Product Description
Product Details:

Brand

MYHEP LVIR

We Rewine Pharmaceutical are a leading Manufacturer and Exporter of MYHEP LVIR TABLET  (Sofosbuvir 400mg + Ledipasvir 90mg ) in different strength and packing. Our manufacturing facility is certified with WHO-GMP.

COMPOSITION :

  • MYHEP LVIR TABLET  (Sofosbuvir 400mg + Ledipasvir 90mg )
  • Brand name: MYHEP LVIR
  • Active Ingeridents(Generic Name) : Sofosbuvir 400mg + Ledipasvir 90mg
  • Company Name: Mylan Pharmaceuticals
  • Strength : 400 mg + 90 mg
  • Package: 28 tabs
  • Pack Type : Bottle

Indication:


MYHEP LVIR Contain Sofosbuvir and Ledipasvir For the treatment of Hepatitis C
Hepatitis C is a liver disease caused by the hepatitis C virus the virus can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness.

  • The hepatitis C virus is a bloodborne virus and the most common modes of infection are through unsafe injection practices, inadequate sterilization of medical equipment, and the transfusion of unscreened blood and blood products.
  • Globally, between 130–150 million people globally have chronic hepatitis C infection.
  • A significant number of those who are chronically infected will develop liver cirrhosis or liver cancer.
  • There is currently no vaccine for hepatitis C; however research in this area is ongoing.

The hepatitis C virus is a bloodborne virus. It is most commonly transmitted through:

  • Injecting drug use through the sharing of injection equipment;
  • The reuse or inadequate sterilization of medical equipment, especially syringes and needles in healthcare settings; and
  • The transfusion of unscreened blood and blood products.

Uses:-
Treating chronic hepatitis C virus (HCV) infection in certain patients.
Ledipasvir and sofosbuvir is a combination of 2 hepatitis C virus (HCV) antiviral agents. It reduces the amount of HCV in the body by preventing the spread of the HCV within the body.


Available other Brand : HEPCINAT LP, LEDIFOS, RESOF L, LEDVICLEAR, HEPCVIR L, , SOFOCURE L, NOVISOF L, LEDIHEP, SOFAB LP, LEDVICLEAR, SOFOCRUZ LP, SOFOKEM L, CIMIVIR L

Trade Information
  • Payment Terms
  • Paypal, Western Union, Telegraphic Transfer (T/T), Letter of Credit (L/C), Cash in Advance (CID), Cash Advance (CA)
  • Delivery Time
  • 30 Days
  • Sample Policy
  • Within a certain price range free samples are available
  • Main Export Market(s)
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
  • Certifications
  • ISO, WHO, GMP

REWINE PHARMACEUTICAL
X


Back to top